Ran BP-3 Activators
Ran BP-3 activators, based on their classification, can act directly or indirectly to modulate the function or expression of Ran BP-3. Notably, direct activators specifically target Ran BP-3, enhancing its activity or influencing its expression levels. On the other hand, indirect activators, such as Leptomycin B, exploit cellular signaling pathways or other cellular mechanisms that eventually result in an impact on Ran BP-3. Leptomycin B, for example, disrupts nuclear export processes, which in turn can influence Ran BP-3, a protein known for its roles in nuclear transport.
A majority of the compounds listed, such as Geldanamycin or Trichostatin A, have been recognized for their broader roles in cellular signaling and regulatory mechanisms. These chemicals, although not explicitly known as direct Ran BP-3 modulators, can inadvertently affect the protein's pathway given their extensive influence on cellular processes. For instance, Geldanamycin's binding to Hsp90 or Trichostatin A's impact on histone deacetylation can lead to a cascade of cellular reactions that potentially modulate Ran BP-3. The implication here is that the cellular context, the presence of other signaling molecules, and the overall health status of the cell can dictate the specific role and influence of these activators on Ran BP-3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin can bind and inhibit heat shock protein 90 (Hsp90). This perturbation indirectly affects various proteins including those in the Ran pathway, possibly affecting Ran BP-3's function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can indirectly influence numerous proteins. Its influence on chromatin remodeling can potentially affect Ran BP-3-associated pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
While primarily known to inhibit mTOR, Rapamycin's wide range of effects on cellular processes can influence pathways associated with Ran BP-3. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Known to influence nuclear transport proteins, potentially affecting the function or localization of Ran BP-3. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A multi-target compound that, among other actions, can influence nuclear transport and related signaling pathways that Ran BP-3 may be involved in. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
As a Rho-associated protein kinase inhibitor, Y-27632 can affect cell signaling pathways that may have downstream effects on Ran BP-3. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that prevents protein degradation. Its action can influence the levels of various proteins, potentially including or affecting Ran BP-3. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
By disrupting microtubule dynamics, Nocodazole can affect various cellular processes, potentially influencing Ran BP-3's function or localization. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
A TGF-beta type I receptor inhibitor. By affecting the TGF-beta pathway, it could have indirect effects on the Ran pathway and Ran BP-3 function. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
A phosphatase inhibitor that affects a variety of signaling pathways. Its broad influence on phosphatase-related pathways might affect Ran BP-3. | ||||||